Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest announcement is out from Phibro Animal Health ( (PAHC) ).
On July 29, 2025, Phibro Animal Health Corporation announced a quarterly cash dividend of $0.12 per share for its Class A and Class B common stock, payable on September 24, 2025, to stockholders recorded by September 3, 2025. This declaration reflects the company’s ongoing commitment to returning value to its shareholders and may influence investor sentiment and market positioning.
The most recent analyst rating on (PAHC) stock is a Sell with a $13.00 price target. To see the full list of analyst forecasts on Phibro Animal Health stock, see the PAHC Stock Forecast page.
Spark’s Take on PAHC Stock
According to Spark, TipRanks’ AI Analyst, PAHC is a Neutral.
Phibro Animal Health’s overall stock score is bolstered by strong earnings call performance with significant revenue and EBITDA growth, as well as positive cash flow metrics. However, the high leverage and overvaluation concerns in the technical analysis and valuation components weigh down the score. The technical indicators suggest bullish momentum, but overbought conditions warrant caution.
To see Spark’s full report on PAHC stock, click here.
More about Phibro Animal Health
Phibro Animal Health Corporation is a leading global diversified animal health and nutrition company, providing solutions to livestock producers, farmers, veterinarians, and consumers to maintain and enhance animal health.
Average Trading Volume: 285,607
Technical Sentiment Signal: Buy
Current Market Cap: $1.17B
For a thorough assessment of PAHC stock, go to TipRanks’ Stock Analysis page.